GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CBD Life Sciences Inc (OTCPK:CBDL) » Definitions » Gross Margin %

CBD Life Sciences (CBD Life Sciences) Gross Margin % : 0.00% (As of Sep. 2015)


View and export this data going back to 2009. Start your Free Trial

What is CBD Life Sciences Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. CBD Life Sciences's Gross Profit for the three months ended in Sep. 2015 was $0.00 Mil. CBD Life Sciences's Revenue for the three months ended in Sep. 2015 was $0.00 Mil. Therefore, CBD Life Sciences's Gross Margin % for the quarter that ended in Sep. 2015 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.


The historical rank and industry rank for CBD Life Sciences's Gross Margin % or its related term are showing as below:


CBDL's Gross Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 46.51
* Ranked among companies with meaningful Gross Margin % only.

CBD Life Sciences had a gross margin of N/A% for the quarter that ended in Sep. 2015 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for CBD Life Sciences was 0.00% per year.


CBD Life Sciences Gross Margin % Historical Data

The historical data trend for CBD Life Sciences's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CBD Life Sciences Gross Margin % Chart

CBD Life Sciences Annual Data
Trend Dec11 Dec12 Dec13 Dec14
Gross Margin %
- - - -

CBD Life Sciences Quarterly Data
Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of CBD Life Sciences's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, CBD Life Sciences's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CBD Life Sciences's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CBD Life Sciences's Gross Margin % distribution charts can be found below:

* The bar in red indicates where CBD Life Sciences's Gross Margin % falls into.



CBD Life Sciences Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

CBD Life Sciences's Gross Margin for the fiscal year that ended in Dec. 2014 is calculated as

Gross Margin % (A: Dec. 2014 )=Gross Profit (A: Dec. 2014 ) / Revenue (A: Dec. 2014 )
=0.1 / 0.123
=(Revenue - Cost of Goods Sold) / Revenue
=(0.123 - 0) / 0.123
=N/A %

CBD Life Sciences's Gross Margin for the quarter that ended in Sep. 2015 is calculated as


Gross Margin % (Q: Sep. 2015 )=Gross Profit (Q: Sep. 2015 ) / Revenue (Q: Sep. 2015 )
=0 / 0
=(Revenue - Cost of Goods Sold) / Revenue
=(0 - 0) / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


CBD Life Sciences  (OTCPK:CBDL) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

CBD Life Sciences had a gross margin of N/A% for the quarter that ended in Sep. 2015 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


CBD Life Sciences Gross Margin % Related Terms

Thank you for viewing the detailed overview of CBD Life Sciences's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


CBD Life Sciences (CBD Life Sciences) Business Description

Traded in Other Exchanges
N/A
Address
10853 N. Frank Llyod Wright Boulevard, Suite 108, Scottsdale, AZ, USA, 85259
CBD Life Sciences Inc is developing and marketing a line of cannabidiol based organic products such as hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a full line of pet products. The company is also in the process of developing an anti-aging skin product line.